295 related articles for article (PubMed ID: 24071738)
21. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling.
Gao S; Alarcón C; Sapkota G; Rahman S; Chen PY; Goerner N; Macias MJ; Erdjument-Bromage H; Tempst P; Massagué J
Mol Cell; 2009 Nov; 36(3):457-68. PubMed ID: 19917253
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the transforming growth factor β pathway by reversible ubiquitylation.
Al-Salihi MA; Herhaus L; Sapkota GP
Open Biol; 2012 May; 2(5):120082. PubMed ID: 22724073
[TBL] [Abstract][Full Text] [Related]
25. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling.
Lin X; Liang M; Feng XH
J Biol Chem; 2000 Nov; 275(47):36818-22. PubMed ID: 11016919
[TBL] [Abstract][Full Text] [Related]
26. Signaling via Smad2 and Smad3 is dispensable for adult murine hematopoietic stem cell function in vivo.
Billing M; Rörby E; Dahl M; Blank U; Andradottír S; Ehinger M; Karlsson S
Exp Hematol; 2017 Nov; 55():34-44.e2. PubMed ID: 28666967
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms involved in suppression of osteoclast supportive activity by transforming growth factor-β1 via the ubiquitin-proteasome system.
Inoue M; Nagai-Yoshioka Y; Yamasaki R; Kawamoto T; Nishihara T; Ariyoshi W
PLoS One; 2022; 17(2):e0262612. PubMed ID: 35196318
[TBL] [Abstract][Full Text] [Related]
28. Sirt1 interaction with active Smad2 modulates transforming growth factor-β regulated transcription.
García-Vizcaíno EM; Liarte S; Alonso-Romero JL; Nicolás FJ
Cell Commun Signal; 2017 Nov; 15(1):50. PubMed ID: 29187201
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of OTUB1-mediated inhibition of ubiquitination.
Wiener R; Zhang X; Wang T; Wolberger C
Nature; 2012 Feb; 483(7391):618-22. PubMed ID: 22367539
[TBL] [Abstract][Full Text] [Related]
30. The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation.
Simonsson M; Kanduri M; Grönroos E; Heldin CH; Ericsson J
J Biol Chem; 2006 Dec; 281(52):39870-80. PubMed ID: 17074756
[TBL] [Abstract][Full Text] [Related]
31. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.
Lin X; Duan X; Liang YY; Su Y; Wrighton KH; Long J; Hu M; Davis CM; Wang J; Brunicardi FC; Shi Y; Chen YG; Meng A; Feng XH
Cell; 2006 Jun; 125(5):915-28. PubMed ID: 16751101
[TBL] [Abstract][Full Text] [Related]
32. Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma.
Abushahba W; Olabisi OO; Jeong BS; Boregowda RK; Wen Y; Liu F; Goydos JS; Lasfar A; Cohen-Solal KA
PLoS One; 2012; 7(10):e47312. PubMed ID: 23077590
[TBL] [Abstract][Full Text] [Related]
33. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta).
Clifford RL; Deacon K; Knox AJ
J Biol Chem; 2008 Dec; 283(51):35337-53. PubMed ID: 18952601
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells.
Fu Y; Chang A; Chang L; Niessen K; Eapen S; Setiadi A; Karsan A
J Biol Chem; 2009 Jul; 284(29):19452-62. PubMed ID: 19473993
[TBL] [Abstract][Full Text] [Related]
35. Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1.
Nakada S; Tai I; Panier S; Al-Hakim A; Iemura S; Juang YC; O'Donnell L; Kumakubo A; Munro M; Sicheri F; Gingras AC; Natsume T; Suda T; Durocher D
Nature; 2010 Aug; 466(7309):941-6. PubMed ID: 20725033
[TBL] [Abstract][Full Text] [Related]
36. Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signaling.
Inoue Y; Kitagawa M; Onozaki K; Hayashi H
J Interferon Cytokine Res; 2004 Jan; 24(1):43-54. PubMed ID: 14980084
[TBL] [Abstract][Full Text] [Related]
37. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells.
Dzwonek J; Preobrazhenska O; Cazzola S; Conidi A; Schellens A; van Dinther M; Stubbs A; Klippel A; Huylebroeck D; ten Dijke P; Verschueren K
Mol Cancer Res; 2009 Aug; 7(8):1342-53. PubMed ID: 19671686
[TBL] [Abstract][Full Text] [Related]
38. The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner.
Nye MD; Almada LL; Fernandez-Barrena MG; Marks DL; Elsawa SF; Vrabel A; Tolosa EJ; Ellenrieder V; Fernandez-Zapico ME
J Biol Chem; 2014 May; 289(22):15495-506. PubMed ID: 24739390
[TBL] [Abstract][Full Text] [Related]
39. Fine-tuning of Smad protein function by poly(ADP-ribose) polymerases and poly(ADP-ribose) glycohydrolase during transforming growth factor β signaling.
Dahl M; Maturi V; Lönn P; Papoutsoglou P; Zieba A; Vanlandewijck M; van der Heide LP; Watanabe Y; Söderberg O; Hottiger MO; Heldin CH; Moustakas A
PLoS One; 2014; 9(8):e103651. PubMed ID: 25133494
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis.
Nan L; Jacko AM; Tan J; Wang D; Zhao J; Kass DJ; Ma H; Zhao Y
Sci Rep; 2016 Sep; 6():33116. PubMed ID: 27604640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
